Mohammad Rahbari
@morahbari.bsky.social
Medical Doctor | Clinician Scientist
Division of Chronic Inflammation and Cancer @dkfz.bsky.social | @uniheidelberg.bsky.social
X: @morahbari
Division of Chronic Inflammation and Cancer @dkfz.bsky.social | @uniheidelberg.bsky.social
X: @morahbari
Reposted by Mohammad Rahbari
ICYMI: New online! Redefining cancer care: the case for an onco-gastroenterology subspecialty
Redefining cancer care: the case for an onco-gastroenterology subspecialty
Nature Reviews Gastroenterology & Hepatology, Published online: 23 May 2025; doi:10.1038/s41575-025-01076-6Onco-gastroenterology is defined as a collaborative subspecialty of Gastroenterology that is dedicated to the unique needs of individuals with or at risk of cancer, with a focus on maintaining and managing their digestive and liver health throughout their clinical course.
www.nature.com
May 29, 2025 at 1:33 PM
ICYMI: New online! Redefining cancer care: the case for an onco-gastroenterology subspecialty
Reposted by Mohammad Rahbari
#CellPlasticity—the ability of cells to change their identity—is vital for tissue growth and repair. But when it goes unchecked, it can fuel #cancer. Our latest study examines how to block #LiverCancer by actively suppressing plasticity. www.nature.com/articles/s41... #CancerBiology
February 13, 2025 at 12:16 PM
#CellPlasticity—the ability of cells to change their identity—is vital for tissue growth and repair. But when it goes unchecked, it can fuel #cancer. Our latest study examines how to block #LiverCancer by actively suppressing plasticity. www.nature.com/articles/s41... #CancerBiology
Reposted by Mohammad Rahbari
ICYMI: New online! MASLD as a non-communicable disease
MASLD as a non-communicable disease
Nature Reviews Gastroenterology & Hepatology, Published online: 04 February 2025; doi:10.1038/s41575-025-01039-xNon-communicable diseases represent the primary cause of mortality and morbidity globally, accounting for 74% of all deaths and more than…
www.nature.com
February 10, 2025 at 9:02 PM
ICYMI: New online! MASLD as a non-communicable disease
Reposted by Mohammad Rahbari
Very happy to share this „viewpoint“ article which was just published in @naturecancer.bsky.social ,
www.nature.com/articles/s43...
www.nature.com/articles/s43...
January 30, 2025 at 6:18 PM
Very happy to share this „viewpoint“ article which was just published in @naturecancer.bsky.social ,
www.nature.com/articles/s43...
www.nature.com/articles/s43...
Reposted by Mohammad Rahbari
˚⋆🔬👨🔬👩🏻🔬Call for Interinstitutional Postdoctoral Positions at The Health + Life Science Alliance Heidelberg Mannheim🔬🧪🥽⋆˚
Registration link on our website www.health-life-sciences.de/postdocs.
Apply by March 28, 2025, 5 pm CET
www.health-life-sciences.de/postdocs
Registration link on our website www.health-life-sciences.de/postdocs.
Apply by March 28, 2025, 5 pm CET
www.health-life-sciences.de/postdocs
February 3, 2025 at 9:20 AM
˚⋆🔬👨🔬👩🏻🔬Call for Interinstitutional Postdoctoral Positions at The Health + Life Science Alliance Heidelberg Mannheim🔬🧪🥽⋆˚
Registration link on our website www.health-life-sciences.de/postdocs.
Apply by March 28, 2025, 5 pm CET
www.health-life-sciences.de/postdocs
Registration link on our website www.health-life-sciences.de/postdocs.
Apply by March 28, 2025, 5 pm CET
www.health-life-sciences.de/postdocs
Reposted by Mohammad Rahbari
ICYMI: New online! Preventing the progression of cirrhosis to decompensation and death
Preventing the progression of cirrhosis to decompensation and death
Nature Reviews Gastroenterology & Hepatology, Published online: 27 January 2025; doi:10.1038/s41575-024-01031-xThis Review describes the progression of advanced chronic liver disease (ACLD) from its early stages (compensated ACLD) to more advanced disease…
www.nature.com
February 2, 2025 at 6:50 PM
ICYMI: New online! Preventing the progression of cirrhosis to decompensation and death
Reposted by Mohammad Rahbari
We tend to think that all decompensated cirrhosis are the same. During the 12 years that I practiced in the USA, I learnt that MASLD cirrhosis is different.
See below the 10 more common specific medical issues of MASLD CIRRHOSIS that I found:
See below the 10 more common specific medical issues of MASLD CIRRHOSIS that I found:
January 29, 2025 at 4:48 AM
We tend to think that all decompensated cirrhosis are the same. During the 12 years that I practiced in the USA, I learnt that MASLD cirrhosis is different.
See below the 10 more common specific medical issues of MASLD CIRRHOSIS that I found:
See below the 10 more common specific medical issues of MASLD CIRRHOSIS that I found:
Reposted by Mohammad Rahbari
#COMMENT 🚨
Zuber and Palm highlight how modelling tumour-specific metabolic conditions can enhance our understanding of cancer biology & improve therapeutic discovery.
📖 👇
https://bit.ly/4ga74...
Zuber and Palm highlight how modelling tumour-specific metabolic conditions can enhance our understanding of cancer biology & improve therapeutic discovery.
📖 👇
https://bit.ly/4ga74...
Modelling and deciphering tumour metabolism in CRISPR screens - Nature Reviews Cancer
CRISPR screens in cell cultures reveal cancer dependencies yet often miss the metabolic nuances of tissues. In this Comment, Zuber and Palm highlight how modelling tumour-specific metabolic conditions can enhance our understanding of cancer biology and improve therapeutic discovery.
bit.ly
January 31, 2025 at 3:03 PM
#COMMENT 🚨
Zuber and Palm highlight how modelling tumour-specific metabolic conditions can enhance our understanding of cancer biology & improve therapeutic discovery.
📖 👇
https://bit.ly/4ga74...
Zuber and Palm highlight how modelling tumour-specific metabolic conditions can enhance our understanding of cancer biology & improve therapeutic discovery.
📖 👇
https://bit.ly/4ga74...